Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Millennium ships Velcade within a week of FDA approval

May 22, 2003

Kirin identifies new antitumor FGFR inhibitors

May 22, 2003

Sankyo describes new compounds with PPARgamma-agonist and antitumor activity

May 22, 2003

Water-soluble etoposide prodrugs prepared and tested by French research team

May 22, 2003

ExonHit Therapeutics claims novel antitumor compounds in recent patent

May 22, 2003

Bexarotene reported effective in parapsoriasis

May 21, 2003

Isis and Ercole collaborate on antisense drugs that regulate alternative RNA splicing

May 21, 2003

Lilly researchers describe new antitumor agents with utility in colorectal cancer

May 21, 2003

Bioenvision signs agreement with Penn for clofarabine

May 20, 2003

New pyrrolidine-based FTase inhibitors under study at Wyeth

May 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...